Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

DSIP Circadian Rhythm Complete Guide 2026: Comparison Table

Before choosing any circadian intervention, understand what each compound actually does versus what it's marketed to do. DSIP GABAergic modulation in VLPO; enhances endogenous slow-wave sleep architecture +23–31% duration, no REM suppression No significant cha

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Before choosing any circadian intervention, understand what each compound actually does versus what it's marketed to do.
  • DSIP
  • GABAergic modulation in VLPO; enhances endogenous slow-wave sleep architecture
  • +23–31% duration, no REM suppression
  • No significant change
  • None observed in 90-day trials
  • Indirect (via improved SCN synchronization over 10–14 days)
  • Restores sleep quality without sedation. Pairs well with light therapy for phase correction
  • Melatonin (1–3mg)
  • MT1/MT2 receptor agonism in SCN; signals sleep timing
  • No measurable increase
  • Reduces latency by 7–12 minutes
  • Minimal at physiologic doses
  • Direct phase advance when timed 5–7 hours before DLMO
  • First-line for phase disorders, ineffective for architecture deficits
  • Benzodiazepines
  • GABA-A receptor agonism; CNS depression
  • −18–35% (suppresses slow-wave sleep)
  • Rapid reduction (10–20 minutes)
  • Develops within 14–28 days
  • None
  • Creates dependency, degrades sleep architecture long-term. Avoid for circadian issues
  • CBT-I (Cognitive Behavioral Therapy for Insomnia)
  • Sleep restriction, stimulus control, cognitive restructuring
  • +12–18% via consolidation of sleep opportunity
  • Variable (improves over 4–8 weeks)
  • Not applicable
  • Indirect (via behavioral consistency)
  • Gold standard for chronic insomnia, no pharmacologic risk. Requires sustained adherence
  • Bright Light Therapy (10,000 lux)
  • Melanopsin activation in retinal ganglion cells; direct SCN input
  • No direct effect
  • Strong phase advance (morning exposure) or delay (evening exposure)
  • Most powerful circadian phase shifter. Combine with DSIP for architecture + timing correction